Overdiagnosis in breast imaging

Breast

Volumn 31, Issue , 2017, Pages 270-273

  Evans, Andy ^a   Vinnicombe, Sarah ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Breast imaging; Mammography; Overdiagnosis; Tomosynthesis; Ultrasound

Indexed keywords

ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SCREENING; DIAGNOSTIC ERROR; DIGITAL BREAST TOMOSYNTHESIS; DISEASE FREE SURVIVAL; FALSE POSITIVE RESULT; HUMAN; LIFE EXPECTANCY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; X-RAY COMPUTED TOMOGRAPHY; ADVERSE EFFECTS; BREAST; BREAST CARCINOMA IN SITU; BREAST TUMOR; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; ECHOMAMMOGRAPHY; FEMALE; HEALTH SERVICE; INTRADUCTAL CARCINOMA; MASS SCREENING; PATHOLOGY; UTILIZATION; X-RAY TOMOGRAPHY;

BREAST; BREAST CARCINOMA IN SITU; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; MEDICAL OVERUSE; TOMOGRAPHY, X-RAY; ULTRASONOGRAPHY, MAMMARY;

EID: 85006063010     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2016.10.011     Document Type: Article

References (29)

1. [1] Myers, E.R., Moorman, P., Gierisch, J.M., Havrilesky, L.J., Grimm, L.J., Ghate, S., et al. Benefits and harms of breast Cancer screening: a systematic review. JAMA 314:15 (2015 Oct 20), 1615–1634.
2. [2] Waller, J., Douglas, E., Whitaker, K.L., Wardle, J., Women's responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study a qualitative study. BMJ Open, 3, 2013, e002703, 10.1136/bmjopen-2013-002703.
3. [3] Waller, J., Whitaker, K.L., Winstanley, K., Power, E., Wardle, J., A survey study of women's responses to information about overdiagnosis in breast cancer screening in Britain. BJC 111 (2013), 1831–1835.
4. [4] Puliti, D., Duffy, S.W., Miccinesi, G., de Koning, H., Lynge, E., Zappa, M., et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 19:Suppl 1 (2012), 42–56.
5. [5] Beckmann, K., Duffy, S.W., Lynch, J., Hiller, J., Farshid, G., Roder, D., Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects. J Med Screen 22 (2015), 127–135.
6. [6] Gunsoy, N.B., Garcia-Closas, M., Moss, S.M., Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom. Breast Cancer Res, 14(6), 2012 Nov 29, R152.
7. [7] Holland, R., Schuurman, J., Hendricks, J., Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 335 (1990), 8688–8694.
8. [8] Francis, A., Thomas, J., Fallowfield, L., Wallis, M., Bartlett, J.M., Brookes, C., et al. Addressing overtreatment of screen detected DCIS; the LORIS trial. EJC 51 (2015), 2296–2303.
9. [9] Duffy, S., Dibden, A., Michalopoulos, D., Offman, J., Parmar, D., Jenkins, J., et al. Detection by screening of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers. Lancet Oncol 17:1 (2016), 109–114.
10. [10] Nickel, B., Barratt, A., Hersch, J., Moynihan, R., Irwig, L., McCaffery, K., How different terminology for ductal carcinoma in situ (DCIS) impacts women's concern and management preferences: a qualitative study. Breast 24 (2015), 673–679.
11. [11] Rakha, Emad A., Lee, Andrew HS., Evans, Andy J., Menon, Sindhu, Assad, Nancy Y., Hodi, Zsolt, et al. Tubular carcinoma of the breast: further evidence to support its excellent prognosis. JCO 28 (2010), 99–104.
12. [12] Min, Y., Bae, S., Lee, H., Lee, J., Kim, M., Kim, J., et al. Tubular carcinoma of the breast: clinicopathologic features and survival outcome compared with ductal carcinoma in situ. J Breast Cancer 16:4 (2013 Dec), 404–409.
13. [13] Skaane, P., Bandos, A., Gullien, R., Ellen, R., Eben, E., Ekseth, U., et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population based screening program. Radiology 267 (2013), 47–56.
14. [14] Lång, K., Andersson, I., Rosso, A., Tingberg, A., Timberg, P., Zackrisson, S., Performance of one-view breast tomosynthesis as a stand-alone breast cancer screening modality: results from the Malmö Breast tomosynthesis screening trial, a population-based study. Euro Radiol 26 (2015), 184–190.
15. [15] Evans, A., Pinder, S., James, J., Ellis, I.O., Cornford, E., Is mammographic spiculation an independent, good prognostic factor in screen detected invasive breast cancer?. AJR 187 (2006), 1–6.
16. [16] Luck, A., Evans, A.J., James, J.J., Rakha, E.A., Paish, E.C., Green, A.R., Ellis, I.O., et al. Breast cancer with basal phenotype: mammographic findings. AJR 191 (2008), 1–6.
17. [17] McDonald, E.S., Oustimov, A., Weinstein, S.P., Synnestvedt, M.B., Schnall, M., Conant, E.F., Effectiveness of digital breast tomosynthesis compared with digital mammography: outcomes analysis from 3 Years of breast Cancer screening. JAMA Oncol, 2016 Feb 18, 10.1001/jamaoncol.2015.5536 [Epub ahead of print].
18. [18] Pettersson, A., Graff, R.E., Ursin, G., Santos Silva, I.D., McCormack, V., Baglietto, L., et al. Mammographic density phenotypes and risk of breast cancer a meta-analysis. J Natl Cancer Inst, 106(5), 2014 May 10, 10.1093/jnci/dju078 pii: dju078.
19. [19] Chiu, S.Y., Duffy, S., Yen, A.M., Tabár, L., Smith, R.A., Chen, H.H., Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomarkers Prev 19 (2010), 1219–1228.
20. [20] Melnikow, J., Fenton, J.J., Whitlock, E.P., Miglioretti, D.L., Weyrich, M.S., Thompson, J.H., et al. Supplemental screening for breast Cancer in women with dense breasts: a systematic review for the U.S. Preventive services task force. Ann Intern Med 164:4 (2016 Feb 16), 268–278.
21. [21] Ohuchi, N., Suzuki, A., Sobue, T., Kawai, M., Yamamoto, S., Zheng, Y.F., et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet 387 (2016), 341–348.
22. [22] Corsetti, V., Houssami, N., Ghirardi, M., Ferrari, A., Speziani, M., Bellarosa, S., et al. Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up. Eur J Cancer 47 (2011), 1021–1026.
23. [23] Berg, W., Zhang, Z., Lehrer, D., Jong, R., Pisano, E., Barr, R.G., et al. Detection of breast Cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast Cancer risk. JAMA 307 (2012), 1394–1404.
24. [24] Turnbull, L., Brown, S., Harvey, I., Olivier, C., Drew, P., Napp, V., et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375 (2010 Feb 13), 563–571.
25. [25] Houssami, N., Turner, R., Morrow, M., Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg 257 (2013 Feb), 249–255.
26. [26] Sung, J.S., Li, J., Da Costa, G., Patil, S., Van Zee, K.J., Dershaw, D.D., et al. Preoperative breast MRI for early-stage breast cancer: effect on surgical and long-term outcomes. AJR Am J Roentgenol 202 (2014 Jun), 1376–1382.
27. [27] Pilewskie, M., Olcese, C., Eaton, A., Patil, S., Morris, E., Morrow, M., et al. Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation. Ann Surg Oncol 21 (2014 May), 1552–1560.
28. [28] Vaidya, J.S., Wenz, F., Bulsara, M., Tobias, J.S., Joseph, D.J., Keshtgar, M., et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet 383 (2014), 603–613.
29. [29] Wang, S.Y., Long, J.B., Killelea, B.K., Evans, S.B., Roberts, K.B., Silber, A., et al. Preoperative breast magnetic resonance imaging and contralateral breast Cancer occurrence among older women with breast Cancer. J Clin Oncol 34 (2016 Feb 1), 321–328.